Medicare Enrolled

Dr. William Cheung, M.D.

Hematology & Oncology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
19 BOWERY FL 2, New York, NY 10002
2122262251
In practice since 2006 (20 years)
NPI: 1629031208 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheung? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheung

Dr. William Cheung is a hematology & oncology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cheung performed 1,282 Medicare services across 734 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheung received a total of $46,968 from 92 pharmaceutical and/or device companies across 2030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 37% volume in NY $46,968 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,282
Medicare services
Top 37% in NY for hematology & oncology
734
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
333 $80 $146
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
181 $50 $91
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
179 $8 $14
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
177 $4 $21
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $105 $206
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
46 $147 $210
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
41 $76 $100
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
40 $35 $50
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
34 $35 $69
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
34 $29 $43
Annual depression screening 32 $21 $30
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
30 $13 $40
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $47 $90
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
17 $63 $134
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
15 $13 $35
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $104 $182
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$46,968
Total received (2018-2024)
Avg $6,710/year across 7 years
Top 12% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
2,030
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$44,012 (93.7%)
Other
Charitable contributions, space rental, and other categories
$2,086 (4.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$869 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,542
2023
$5,662
2022
$5,883
2021
$7,051
2020
$5,389
2019
$7,771
2018
$9,670

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$680
Novartis Pharmaceuticals Corporation
$638
AstraZeneca Pharmaceuticals LP
$474
Merck Sharp & Dohme LLC
$373
Janssen Biotech, Inc.
$371
Amgen Inc.
$265
PFIZER INC.
$247
Incyte Corporation
$218
Rigel Pharmaceuticals, Inc.
$195
Eisai Inc.
$195
Exact Sciences Corporation
$172
GlaxoSmithKline, LLC.
$161
Novo Nordisk Inc
$160
Exelixis Inc.
$159
ABBVIE INC.
$144
Lilly USA, LLC
$132
SOBI, INC
$117
Bayer Healthcare Pharmaceuticals Inc.
$85
GENZYME CORPORATION
$77
Regeneron Healthcare Solutions, Inc.
$75
Astellas Pharma US Inc
$73
ARRAY BIOPHARMA INC
$68
PharmaEssentia USA Corporation
$62
PUMA BIOTECHNOLOGY, INC.
$57
TAIHO ONCOLOGY, INC.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$45
Agios Pharmaceuticals, Inc.
$42
Hologic Sales and Service, LLC
$30
Genmab U.S., Inc.
$24
JAZZ PHARMACEUTICALS INC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Daiichi Sankyo Inc.
$21
Mannkind Corporation
$21
Adaptive Biotechnologies Corporation
$19
RECORDATI_RARE_DISEASES_INC.
$19
Celgene Corporation
$17
Mirati Therapeutics, Inc.
$14
Top 3 companies account for 32.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$6,418
Gilead Sciences, Inc.
$4,343
AstraZeneca Pharmaceuticals LP
$3,036
Amgen Inc.
$2,673
E.R. Squibb & Sons, L.L.C.
$2,538
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,131
PFIZER INC.
$2,105
Janssen Biotech, Inc.
$1,399
Lilly USA, LLC
$1,305
Novo Nordisk Inc
$1,261
Incyte Corporation
$1,259
GlaxoSmithKline, LLC.
$1,205
Merck Sharp & Dohme Corporation
$1,126
Merck Sharp & Dohme LLC
$1,034
Genentech USA, Inc.
$837
GENZYME CORPORATION
$790
Rigel Pharmaceuticals, Inc.
$671
Radius Health, Inc.
$631
Astellas Pharma US Inc
$582
Seagen Inc.
$550
Eisai Inc.
$547
AbbVie Inc.
$531
Takeda Pharmaceuticals U.S.A., Inc.
$496
Celgene Corporation
$478
Puma Biotechnology, Inc.
$440
Bayer HealthCare Pharmaceuticals Inc.
$404
Exelixis Inc.
$401
SANOFI-AVENTIS U.S. LLC
$390
ARRAY BIOPHARMA INC
$379
ABBVIE INC.
$356
Regeneron Healthcare Solutions, Inc.
$347
SOBI, INC
$341
AbbVie, Inc.
$321
Dova Pharmaceuticals
$321
Janssen Pharmaceuticals, Inc
$317
Amarin Pharma Inc.
$316
EISAI INC.
$309
Seattle Genetics, Inc.
$273
PUMA BIOTECHNOLOGY, INC.
$239
Foundation Medicine, Inc.
$212
Mirati Therapeutics, Inc.
$206
Pharmacyclics LLC, An AbbVie Company
$181
Exact Sciences Corporation
$172
NOVARTIS PHARMACEUTICALS CORPORATION
$167
TESARO, Inc.
$164
Medtronic, Inc.
$155
EMD Serono, Inc.
$144
Mannkind Corporation
$142
Esperion Therapeutics, Inc.
$128
Janssen Scientific Affairs, LLC
$124
MannKind Corporation
$120
Teva Pharmaceuticals USA, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$102
Sobi, Inc
$101
Kite Pharma, Inc.
$101
Vifor Pharma, Inc.
$87
Allergan Inc.
$83
Global Blood Therapeutics, Inc.
$80
Allergan, Inc.
$79
TAIHO ONCOLOGY, INC.
$78
Verastem, Inc.
$66
West-Ward Pharmaceuticals
$64
Myovant Sciences Inc.
$64
Clovis Oncology, Inc.
$63
PharmaEssentia USA Corporation
$62
Pharmacyclics LLC, an AbbVie Company
$61
Jazz Pharmaceuticals Inc.
$60
Sumitomo Pharma America, Inc.
$60
Seqirus USA Inc
$54
JAZZ PHARMACEUTICALS INC.
$43
Nestle HealthCare Nutrition Inc.
$43
Agios Pharmaceuticals, Inc.
$42
EUSA Pharma (US) LLC
$41
IBSA Pharma Inc.
$35
Ironwood Pharmaceuticals, Inc
$34
Hologic Sales and Service, LLC
$30
AVEO Pharmaceuticals, Inc.
$26
Deciphera Pharmaceuticals Inc.
$24
Genmab U.S., Inc.
$24
Acerta Pharma LLC
$22
Daiichi Sankyo Inc.
$21
SANOFI PASTEUR INC.
$20
Myriad Genetic Laboratories, Inc.
$20
Adaptive Biotechnologies Corporation
$19
RECORDATI_RARE_DISEASES_INC.
$19
OptiNose US, Inc.
$19
CTI BioPharma Corp.
$19
RedHill Biopharma Inc.
$18
Relypsa, Inc.
$17
MorphoSys, US Inc.
$16
Hikma Pharmaceuticals USA
$14
Helsinn Therapeutics (U.S.), Inc.
$13
Top 3 companies account for 29.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AFREZZA · AIRSUPRA · ALOXI · ANORO · ANORO ELLIPTA · AREXVY · Abraxane · Aimovig · Alecensa · Avastin · BALVERSA · BASAGLAR · BAVENCIO · BELSOMRA · BENDEKA · BESREMI · BEVESPI AEROSPHERE · BOSULIF · BRAFTOVI · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CREON · CYRAMZA · Cabometyx · Cologuard Collection Kit · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EUCRISA · EVENITY · Enhertu · Epclusa · Epkinly · Erleada · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · Fabhalta · GARDASIL · GILOTRIF · GLYXAMBI · GRANIX · Halaven · IBRANCE · ICLUSIG · ILLUMISITE · IMBRUVICA · IMFINZI · INLYTA · INVOKANA · Imbruvica · Inrebic · JAKAFI · JANUVIA · JARDIANCE · JAYPIRCA · JENTADUETO · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kerendia · LIBTAYO · LINZESS · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Licart · Linzess · Localizer · MEKINIST · MONJUVI · MOUNJARO · Mitigare · Movantik · NAMZARIC · NERLYNX · NEXLETOL · NINLARO · NURTEC ODT · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Otezla · Ozempic · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROMACTA · PYRUKYND · Perjeta · Pomalyst · Prolia · QINLOCK · QULIPTA · REBLOZYL · RETEVMO · RYBELSUS · RYBREVANT · RYDAPT · Repatha · Revlimid · Rezlidhia · Rubraca · Rybelsus · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRYCEL · STIOLTO RESPIMAT · SYLVANT · SYMBICORT · SYNJARDY · SYNTHROID · Stivarga · Sylvant · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tresiba · Trodelvy · Truxima · Tymlos · UBRELVY · VERZENIO · VOTRIENT · VRAYLAR · Vascepa · Vectibix · Veltassa · Vemlidy · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xhance · Xospata · Xtandi · ZEJULA · ZENPEP · ZEPZELCA · ZYTIGA · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in New York?
Compare hematology & oncology specialists in the New York area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
726
Per 100K population
44.6
County median income
$104,553
Nearest hospital
NY EYE AND EAR INFIRMARY OF MOUNT SINAI
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cheung is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cheung experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cheung performed 333 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheung receive payments from pharmaceutical companies?
Yes. Dr. Cheung received a total of $46,968 from 92 companies across 2,030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheung's costs compare to other hematology & oncology specialists in New York?
Dr. Cheung's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →